
Bulletin of the Chemical Society of Japan p. 1827 - 1835 (1999)
Update date:2022-08-05
Topics:
Iwai, Michio
Yamada, Hisashi
Ishii, Yoshinori
Tamura, Kouichi
Niwa, Mineo
Kobayashi, Masakazu
The primary structure of human IGF-I, except for the disulfide bond system, has been reported by Rinderknecht and Humbel. IGF-I afforded the corresponding characteristic peptide fragments on V8 protease digestion, which contained Cys6, Cys47, Cys48, and Cys52. Two possible fragments, Type I with Cys6-Cys47 and Cys48-Cys52 and Type II with Cys6-Cys48 and Cys47-Cys52 of h-IGF-I(4-9,47-53), were chemically synthesized. The disulfide bond system of IGF-I was unequivocally determined to be the Type-II form along with Cys18-Cys61. Interestingly, the Type-I system was included in the disulfide bond isomer produced as the main by-product in the refolding step on IGF-I synthesis by the recombinant DNA method.
View Morejiangsu hualin chemical co.,ltd.
Contact:86-25-87787402
Address:jaingsu,china
Xiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
Nantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Liaoyang Xinyou Chemical Products Co.,Ltd.
Contact:+86-419-5165433 13604191870
Address:Huishang Road6-1, Hongwei District, Liaoyang, Liaoning, China
Doi:10.1016/S0022-328X(99)00261-2
(1999)Doi:10.1021/acs.orglett.7b02109
(2017)Doi:10.1039/c5gc01333j
(2015)Doi:10.1016/S0960-894X(02)00537-1
(2002)Doi:10.1016/j.ejmech.2015.07.023
(2015)Doi:10.1021/jo026582f
(2003)